4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000120
EVP, Chief Scientific Officer sold 1,272 shares at $480.00 ($610,560)
- EVP, Chief Scientific Officer gave up 5,954 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ALTSHULER DAVID · EVP, Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-26 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −5,954 | $479.61 | $2,855,598 | 34,246 | D |
| 2025-02-27 | Sale : show line 2 in the form 10b5-1 | −1,272 | $480.00 | $610,560 | 32,974 | D |
| Open-market sales · 1,272 sh · avg $480.00 · $610,560 | ||||||
Loading xslF345X05/wk-form4_1740777806.xml…